HEPA, PM2.5, and Cardiometabolic Health
NCT05718245
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Air Pollution
- Cardiometabolic Health
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 65 to 84 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Southern California
- Last updated on ClinicalTrials.gov
- August 1, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Keck School of Medicine, University of Southern California · Los Angeles, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.